SCHEMBL27588484

SCHEMBL27588484

NCc1cccc(C2=CC=N[N]2)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK8 P49336 1/20 0.42
▸ PNMT P11086 1/20 0.40
▸ ENPP2 Q13822 1/20 0.40
▸ LOXL2 Q9Y4K0 2/20 0.39
▸ TAAR1 Q96RJ0 3/20 0.38
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ NOS2 P35228 1/20 0.38
▸ KARS1 Q15046 1/20 0.37
▸ CFD P00746 2/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ FGFR2 P21802 1/20 0.36
▸ FGFR3 P22607 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ PLAU P00749 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ ADRB2 P07550 1/20 0.34
▸ PRMT6 Q96LA8 1/20 0.34
▸ CSNK2A1 P68400 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27606576 0.82 HRH3 (0.50) LOXL2TAAR1CYP2A6HRH3ADRB2
SCHEMBL27588588 0.79 HTR7 (0.46) TAAR1NOS1HRH3
SCHEMBL27606266 0.77 MAOA (0.47) ENPP2
SCHEMBL3791745 0.74 LOXL2 (0.60) CDK8PNMTENPP2LOXL2TAAR1
SCHEMBL16719914 0.72 PNMT (0.40) CDK8PNMTENPP2LOXL2TAAR1
SCHEMBL27588592 0.72 PNMT (0.40) PNMTENPP2LOXL2NOS3NOS1
SCHEMBL27588599 0.69 DYRK1A (0.50) CYP2A6
SCHEMBL3794460 0.69 TAAR1 (0.70) CDK8PNMTENPP2LOXL2TAAR1
SCHEMBL43554 0.69 TAAR1 (0.70) PNMTENPP2LOXL2TAAR1CFD
SCHEMBL29400616 0.69 TAAR1 (0.70) PNMTENPP2LOXL2TAAR1CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 — — CN disclosed
Send feedback